Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA delay
Biotech
FDA delays decision on Merus' first-in-class cancer drug
The agency has pushed back the decision date by three months to give its staff more time to assess recently submitted information.
Nick Paul Taylor
Nov 5, 2024 9:14am
FDA demands data on 2 PTC candidates, delaying filing
Oct 27, 2023 7:30am
FDA resource constraints delay decision on Iovance cell therapy
Sep 15, 2023 5:20am
FDA delays decision on Valneva's chikungunya vaccine by 3 months
Aug 14, 2023 6:00am
FDA again delays Daiichi challenge to Astellas, Novartis in AML
Apr 21, 2023 9:25am
FDA thwarts Astellas' accelerated approval ambition in menopause
Feb 20, 2023 7:20am